SPY334.33+2.22 0.67%
DIA273.90+1.90 0.70%
IXIC11,108.07+109.67 1.00%

Provention Bio Q3 EPS $(0.24) Down From $(0.17) YoY

Provention Bio (NASDAQ:PRVB) reported quarterly losses of $(0.24) per share. This is a 41.18 percent decrease over losses of $(0.17) per share from the same period last year.

Benzinga · -

Provention Bio (NASDAQ:PRVB) reported quarterly losses of $(0.24) per share. This is a 41.18 percent decrease over losses of $(0.17) per share from the same period last year.